FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+4.39%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$1.25B
(-4%)
Cap. Flow
+$6.91M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
77.76%
Holding
39
New
4
Increased
7
Reduced
2
Closed
4
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$17.5M |
| 2 |
ESSA Pharma
EPIX
|
$9.2M |
| 3 |
Immunovant
IMVT
|
$8.15M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$6.72M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$5.23M |
Top Sells
| 1 |
Collegium Pharmaceutical
COLL
|
$18.9M |
| 2 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$9.72M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$9.21M |
| 4 |
Cardiff Oncology
CRDF
|
$2.55M |
| 5 |
ARS Pharmaceuticals
SPRY
|
$1.66M |
Sector Composition
| 1 | Healthcare | 96.1% |
